Similarly, the 10-year DFS was 74.4% for HER2neu-positive patients (4 recurrences) and 61% for HER2neu-negative patients (40 recurrences), but the difference did not reach statistical significance (log-rank test: χ 2 = 0.4, df = 1, p = 0.5).
← all excerpts
Ten-year survival in early-stage breast cancer patients in a comprehensive breast cancer care program in India.
1
0.5000
0.5000